---
title: "Sensodyne 制造商 Haleon 的收入因口腔健康业务增长而增加——更新"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/284518031.md"
description: "Haleon 报告第一季度有机收入增长 2.2%，主要得益于其口腔健康部门，特别是 Sensodyne 和 Parodontax，增长达 8.3%。总收入增加 0.1%，达到 28.6 亿英镑。然而，增长受到寒冷和流感季节疲软的影响，呼吸和消化健康类别出现下降。北美的有机收入增长 1%。公司预计全年有机增长为 3% 至 5%"
datetime: "2026-04-29T08:01:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284518031.md)
  - [en](https://longbridge.com/en/news/284518031.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284518031.md)
---

# Sensodyne 制造商 Haleon 的收入因口腔健康业务增长而增加——更新

By Aimee Look

Haleon booked a rise in organic revenue, led by growth in its oral health segment with brands like Sensodyne toothpaste.

The maker of Panadol and Advil tablets said revenue for the first quarter rose 2.2% on an organic basis, while company-compiled analyst estimates expected organic growth of 2.3%.

Reported revenue rose 0.1% to 2.86 billion pounds ($3.87 billion).

The U.K. consumer health giant's strongest product category was oral health, with 8.3% organic growth--driven by Sensodyne and Parodontax products, Haleon said. The two products had double-digit growth, off the back of geographic expansion and innovation, it said.

The company has leaned into oral health to offset weaker product categories like respiratory and digestive health amid a milder cold and flu season. Growth in oral health was "tempered by a weak cold and flu season," Chief Executive Officer Brian McNamara said.

Organic revenue for its digestive health category, which houses brands like Tums, fell 0.4% on-year for the first quarter. Meanwhile, revenue for its respiratory health category fell 3.4% over the same period on an organic basis.

Revenue in North America rose 1% on an organic basis to 932 million pounds, returning to growth despite a weak cold and flu season.

The company said it expects organic revenue growth of 3% to 5% for the full year.

Write to Aimee Look at aimee.look@wsj.com

(END) Dow Jones Newswires

April 29, 2026 03:48 ET (07:48 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### 相关股票

- [HLN.US](https://longbridge.com/zh-CN/quote/HLN.US.md)

## 相关资讯与研究

- [流感药物需求持续疲软 HaleonQ1 有机销售额不及预期](https://longbridge.com/zh-CN/news/284520038.md)
- [并购驱动首笔营收，美国家族办公室一季度扭亏为盈](https://longbridge.com/zh-CN/news/286920035.md)
- [Xponential Fitness 任命 Danielle Porto Parra 为总裁，强化加盟运营体系](https://longbridge.com/zh-CN/news/286789211.md)
- [专访国务院发展研究中心市场经济研究所研究员王微：文商旅融合也要找到 “专精特新” 模式｜深蓝智库 2026](https://longbridge.com/zh-CN/news/286858764.md)
- [从单点突破到体系作战：健康元 2026 年的呼吸赛道布局逻辑](https://longbridge.com/zh-CN/news/287195308.md)